The promise and perils of biomarker testing in gynecologic cancers

•Biomarker testing is crucial for personalized medicine, offering benefits in treatment precision, prognosis and outcomes.•Overcoming barriers to biomarker testing utilization is essential for equitable access and optimal care for all patients.•Implementing policy change, clinical pathways, and educ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology Jg. 201; S. 53 - 55
Hauptverfasser:	Fitch, Katherine C., Previs, Rebecca A., Moss, Haley A.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Elsevier Inc 01.10.2025
Schlagworte:	Hematology, Oncology, and Palliative Medicine Obstetrics and Gynecology
ISSN:	0090-8258, 1095-6859, 1095-6859
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•Biomarker testing is crucial for personalized medicine, offering benefits in treatment precision, prognosis and outcomes.•Overcoming barriers to biomarker testing utilization is essential for equitable access and optimal care for all patients.•Implementing policy change, clinical pathways, and educational programs can enhance the effective use of biomarker testing.
Bibliographie:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	0090-8258 1095-6859 1095-6859
DOI:	10.1016/j.ygyno.2025.07.019